Hara Capital LLC Buys 1,957 Shares of Smith & Nephew plc (NYSE:SNN)

Hara Capital LLC raised its stake in shares of Smith & Nephew plc (NYSE:SNN) by 391.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,457 shares of the medical equipment provider’s stock after acquiring an additional 1,957 shares during the quarter. Hara Capital LLC’s holdings in Smith & Nephew were worth $60,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. International Assets Investment Management LLC bought a new stake in Smith & Nephew during the 3rd quarter valued at $792,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Smith & Nephew by 29.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 27,199 shares of the medical equipment provider’s stock valued at $847,000 after purchasing an additional 6,164 shares during the last quarter. Stifel Financial Corp purchased a new stake in shares of Smith & Nephew during the 3rd quarter valued at $1,258,000. Maverick Capital Ltd. purchased a new stake in shares of Smith & Nephew during the 3rd quarter valued at $2,086,000. Finally, Raymond James & Associates lifted its holdings in shares of Smith & Nephew by 172.1% during the 3rd quarter. Raymond James & Associates now owns 128,854 shares of the medical equipment provider’s stock valued at $4,013,000 after purchasing an additional 81,500 shares during the last quarter. Institutional investors own 25.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on SNN. Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. StockNews.com lowered Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft lowered Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st.

Smith & Nephew Stock Performance

Shares of SNN stock opened at $25.72 on Tuesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The business has a fifty day moving average of $25.02 and a 200 day moving average of $27.41. Smith & Nephew plc has a 1 year low of $23.65 and a 1 year high of $31.72.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.